Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.

C. Nishimura,T. Nishimura,N. Tanaka,H. Suzuki
DOI: https://doi.org/10.7164/ANTIBIOTICS.40.1794
1987-12-25
Abstract:apeutic activity for squamous cell carcinoma and malignant lymphoma. Human and animal tissues contain BLMhydrolase, which hydrolyzes the carboxamide bond in the pyrimidoblamic acid moiety. The hydrolyzed antibiotic shows little antitumor activity. Therefore, inhibitors of BLMhydrolase are expected to increase the therapeutic activity of BLM.We have purified BLMhydrolase from rabbit liver using a mono-
What problem does this paper attempt to address?